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Effect of Optaflexx and days on feed on feedlot performance, carcass
characteristics, and skeletal muscle gene expression in yearling steers
Abstract
Two-thousand two-hundred fifty-two yearling steers (690 lb) were used to evaluate the effects of
Optaflexx and days on feed on finishing steer performance and carcass characteristics. Treatment groups
included serial harvest dates of 150, 171, or 192 days. Within each harvest date, steers either received
Optaflexx (200 mg/steer daily of ractopamine-HCl) for the final 28 days, or did not receive Optaflexx. All
steers were initially implanted with Revalor-IS and were re-implanted with Revalor-S after 75 days on feed.
At harvest, muscle samples from the inside round were obtained for mRNA analysis of the β- adrenergic
receptors (AR). Optaflexx increased daily gains, hot carcass weight, and ribeye area, and improved feed
efficiency. Optaflexx did not affect dressing percentage, USDA yield grade, or quality grade. Optaflexx did
not change overall feed intake across the entire feeding period, but feed intake was increased during the
28-day period that steers received Optaflexx. As expected, greater days on feed decreased daily gains,
overall feed intake, and the number of yield grade 1 and 2 carcasses, and worsened feed efficiency. Also,
greater days on feed increased hot carcass weight, dressing percentage, and the number of prime and
choice carcasses, as well as the number of yield grade 4 and 5 carcasses. Increasing days on feed
decreased the abundance of mRNA for β1-AR and β3-AR, and increased the abundance of β2-AR mRNA.
Optaflexx had no effect on abundance of mRNA for β1-AR or β3-AR, but it increased the abundance of
mRNA for β2-AR. Optaflexx may affect expression of the β2-AR gene in skeletal muscle, which could
impact the performance responses to Optaflexx feeding in steers.
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Beef Cattle Research – 2006

EFFECT OF OPTAFLEXX1 AND DAYS ON FEED ON FEEDLOT PERFORMANCE,
CARCASS CHARACTERISTICS, AND SKELETAL MUSCLE GENE
EXPRESSION IN YEARLING STEERS
S. J. Winterholler, G. L. Parsons, E. K. Sissom, J. P. Hutcheson2,
R. S. Swingle3, and B. J. Johnson

Summary
Two-thousand two-hundred fifty-two yearling steers (690 lb) were used to evaluate the
effects of Optaflexx and days on feed on finishing steer performance and carcass characteristics. Treatment groups included serial
harvest dates of 150, 171, or 192 days. Within
each harvest date, steers either received Optaflexx (200 mg/steer daily of ractopamineHCl) for the final 28 days, or did not receive
Optaflexx. All steers were initially implanted
with Revalor4-IS and were re-implanted with
Revalor-S after 75 days on feed. At harvest,
muscle samples from the inside round were
obtained for mRNA analysis of the βadrenergic receptors (AR). Optaflexx increased daily gains, hot carcass weight, and
ribeye area, and improved feed efficiency. Optaflexx did not affect dressing percentage,
USDA yield grade, or quality grade. Optaflexx did not change overall feed intake
across the entire feeding period, but feed intake was increased during the 28-day period
that steers received Optaflexx. As expected,
greater days on feed decreased daily gains,
overall feed intake, and the number of yield
grade 1 and 2 carcasses, and worsened feed
efficiency. Also, greater days on feed in-

creased hot carcass weight, dressing percentage, and the number of prime and choice carcasses, as well as the number of yield grade 4
and 5 carcasses. Increasing days on feed decreased the abundance of mRNA for β1-AR
and β3-AR, and increased the abundance of β2AR mRNA. Optaflexx had no effect on abundance of mRNA for β1-AR or β3-AR, but it
increased the abundance of mRNA for β2-AR.
Optaflexx may affect expression of the β2-AR
gene in skeletal muscle, which could impact
the performance responses to Optaflexx feeding in steers.
Introduction
Previous results with Optaflexx, an approved β-adrenergic agonist for beef cattle,
have demonstrated increased daily gains, improved feed efficiency, increased carcass
weight gain, and sometimes a slightly enhanced yield grade without detrimental effects
on quality grade. No studies have determined
if the response to Optaflexx is affected by the
length of the total feeding period. Further,
many studies report that the active ingredient
of Optaflexx, ractopamine-HCl, functions as a
β1-adrenergic receptor agonist. Previous research has suggested that exposure to a β-
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agonist, such as ractopamine-HCl, can affect
the amount of the β-adrenergic receptor (AR)
through which ractopamine mediates its biological effect.
The objectives of our study were to evaluate the effects of feeding Optaflexx to yearling
steers, harvested at three different harvest
dates, on performance, carcass characteristics,
and the abundance of β-adrenergic receptor
mRNA in skeletal muscle tissue.
Experimental Procedures
This study was a collaboration between
Intervet, Inc. (Millsboro, DE), Cactus Research, LTD, and Kansas State University.
Two-thousand two-hundred fifty-two English
× Continental steers (690 lb initial weight)
were fed at Cactus Research, LTD. Treatments were arranged in a 3 × 2 factorial, and
the experiment used a randomized completeblock design. Steers were blocked by arrival
time, randomly assigned to treatments within
block, and allotted to 24 pens, with 91 to 97
steers per pen. Pens of steers were assigned to
harvest dates of 150, 171, or 192 days. Within
each harvest date, steers either received Optaflexx (200 mg/steer daily of ractopamineHCl) for the final 28 days, or did not receive
Optaflexx (control).
Upon entering the
feedyard, steers were implanted with RevalorIS (80 mg trenbolone acetate and 16 mg estradiol-17β), and 75 days later were reimplanted
with Revalor-S (120 mg trenbolone acetate
and 24 mg estradiol-17β). USDA yield and
quality grades were obtained at harvest.
At harvest, a muscle sample was collected
from the inside round of four randomly selected steers in each pen, snap-frozen, and
shipped to the growth lab at Kansas State
University. Samples were stored at -112°F,
and RNA was isolated from the muscle tissue
of two steers in each group. RNA was isolated by using the TRI Reagent RNA isolation

technique. After isolation, RNA quality and
quantity were measured; then the abundance
of mRNA for β1-AR, β2-AR, and β3-AR was
measured by using a reverse transcriptionpolymerase chain reaction procedure.
Results and Discussion
Feeding Optaflexx increased average daily
gain by 4.6% and improved feed efficiency by
3.8% (Table 1). There was no overall change
in dry matter intake in response to Optaflexx
during the entire feeding period, but during
the 28 days in which Optaflexx was fed, feed
intake did increase by 3.5%, compared with
that of controls (data not shown).
Table 1. The effects of Optaflexx on steer
performance and carcass characteristics
Treatment
Item

Control Optaflexx
a

Total gain, lb

570

Dry matter intake, lb/day
Daily gain, lb/daya
a

Feed:gain

Dressing percentage
Hot carcass weight, lb

a

% carcasses > 949 lb

19.64

3.43

3.59

5.70

5.49

63.30

63.60

3.90

1

492

Marbling score

a

Ribeye area, square inches
USDA yield grade

19.50

816

a

601

834
8.30
496

14.05

14.32

2.8

2.8

Optaflexx, P ≤ 0.05.
500 = small/choice.

a

1

Optaflexx did not significantly alter dressing percentage, but it increased hot carcass
weight by 17 lb. There were also a greater
number of heavy weight carcasses when Optaflexx was fed. Feeding Optaflexx increased
ribeye area in cattle by 1.9%, but had no sig-
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nificant impact on the USDA quality and yield
grades of the carcasses.
As expected, greater time on feed increased hot carcass weight, dressing percentage, and the percentage of USDA Prime and
Choice carcasses. The number of yield grade
4 and 5 carcasses also was increased as days
on feed increased. In addition, cattle performance worsened as time on feed increased;
there were decreases in average daily gain and
overall feed intake, and an increase in
feed:gain (Table 2). The inclusion of Optaflexx in the diet for 28 days before each of
the harvest dates provided a positive performance response in each of the three groups (data
not shown).
Table 2. The effects of days on feed on steer
performance and carcass characteristics
Days on Feed
Item

150

171

192

Total gain, lba

564

571

620

19.7

19.7

19.3

3.8

3.4

3.3

5.18

5.79

5.83

Dry matter intake,
lb/day
Daily gain, lb/day
Feed:gain

a

a
a

Dressing percentage

Hot carcass weight, lb

62.4
a

% carcasses > 949 lba
a,1

Marbling score

Ribeye area,
square inchesa
a

USDA yield grade
a

Days on feed, P ≤ 0.05.
500 = small/choice.

1

790

63.6
823

64.2

Optaflexx had no effect on the abundance
of β1-AR mRNA or β3-AR mRNA (data not
shown), but there was an Optaflexx effect on
the abundance of β2-AR mRNA (Figure 1).
Also, the abundance of β1-AR mRNA and β3AR mRNA decreased as days on feed increased (Figures 2 and 4). Conversely, β2-AR
mRNA abundance increased as days on feed
increased (Figure 3). The amount of β2-AR
mRNA was nearly 200 times greater than the
amount of β1-AR mRNA after 171 days on
feed, and was approximately 160 times greater
at 192 days on feed.
It is believed that ractopamine-HCl mediates its response through the β1-AR. The data
from this study show a decrease in β1-AR
mRNA as cattle are on feed for a longer period of time, but there was still a positive response to Optaflexx for all three harvest dates.
In addition, there was an increase in the abundance of β2-AR mRNA as days on feed increased, and feeding Optaflexx also increased
the abundance of β2-AR mRNA. The results
from this study provide evidence that cattle
preferentially express more β2-adrenergic receptors with increasing days on feed. These
changes could have dramatic effects on performance if a high-affinity, β2 adrenergic agonist (not ractopamine-HCl) was fed during this
period.

862

1.4

4.8

12.1

477

493

511

13.88

14.06

14.62

2.7

2.9

2.8

Our data showed that Optaflexx feeding
numerically increased the expression of the
β2-adrenergic receptor and had no effect on
the β1-adrenergic receptor. Much in vitro research suggests that a specific ligand down
regulates its own receptor over time. Our data
does not support previous findings because the
β1-adrenergic receptor was not affected, and
the β2-adrenergic receptor abundance increased, due to Optaflexx feeding.
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Figure 2. The abundance of β1-adrenergic
receptor mRNA at three different harvest
dates.
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Figure 1. Main effects of Optaflexx on β2adrenergic receptor mRNA.
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Figure 3. The abundance of β2-adrenergic
receptor mRNA at three different harvest
dates.

Figure 4. The abundance of β3-adrenergic
receptor mRNA at three different harvest
dates.
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